AlphaCrest Capital Management LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$222,000
-36.6%
4,416
-49.5%
0.01%
-17.6%
Q2 2022$350,000
-35.3%
8,743
-39.7%
0.02%
-43.3%
Q1 2022$541,000
-32.8%
14,490
-28.3%
0.03%0.0%
Q4 2021$805,000
-33.4%
20,222
-37.7%
0.03%
-51.6%
Q3 2021$1,208,000
+38.2%
32,476
+57.0%
0.06%
+63.2%
Q2 2021$874,000
+45.4%
20,686
+62.9%
0.04%
+15.2%
Q1 2021$601,000
+153.6%
12,697
+226.3%
0.03%
+65.0%
Q4 2020$237,000
-37.5%
3,891
-52.0%
0.02%
-51.2%
Q3 2020$379,000
+86.7%
8,104
+103.0%
0.04%
+20.6%
Q2 2020$203,000
-36.2%
3,993
-57.6%
0.03%
+78.9%
Q3 2019$318,0009,4100.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders